Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

February 7, 2022

Date of Patent

October 10, 2023

Patent Application Number

17666201

Patent Citations

‌

US Patent 10858394 Preparation and uses of reactive oxygen species scavenger derivatives

‌

US Patent 10905775 Particulate constructs for release of active agents

‌

US Patent 10912754 Methods and compositions for treating excessive sleepiness

‌

US Patent 10925844 Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state

‌

US Patent 10933143 Modified release formulations containing drug-ion exchange resin complexes

‌

US Patent 10940133 Methods of providing solriamfetol therapy to subjects with impaired renal function

‌

US Patent 10941107 Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof

‌

US Patent 10952986 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 10959956 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

‌

US Patent 10959976 Methods and compositions for treating excessive sleepiness

•••

Patent Inventor Names

Jean-François Dubuisson

Claire Mégret

Cendrine Grangeon

Jordan Dubow

Hervé Guillard

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11779557

Patent Primary Examiner

CPC Code

•••

Find more entities like US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API